The U.S. urgent care market is expected to surpass around USD 34.95 billion by 2030, poised to grow at a CAGR of 6.8% from 2022 to 2030
Increase in incidence of chronic diseases, rising affordability of emergency care, and growing demand for cost-effective treatment for geriatric population are factors likely to drive the market during the forecast period.
The U.S. urgent care market is expected to witness high growth in the coming years due to increasing investments by service providers and growing recognition and need to provide affordable care. In addition, growing medical coverage is anticipated to propel market growth. According to the Patient Protection and Affordable Care (PPAC) Act, 2010, approximately 32 million individuals were insured in U.S.
Various strategic initiatives such as partnerships, collaborations, mergers and acquisitions are likely to boost the urgent care market. For instance, in June 2018, CityMD acquired STAT Health to expand its services to 100 locations in New York City. This acquisition is expected to help address healthcare challenges and provide coordinated care.
Hospitals are increasing their interest in UC centers to maintain the balance between emergency and primary care in hospitals. UC centers now possess tools for diagnosis, blood testing, screening, radiology. Companies and the U.S. government, in collaboration with UC centers, organize certain wellness programs for improvement of health status of the nation’s population. Introduction of telemedicine is assisting these centers and enabling comfortable consultation for acute conditions.
Scope of The Report
Report Coverage | Details |
Revenue Forecast by 2030 | USD 34.95 billion |
Growth rate from 2022 to 2030 | CAGR of 6.8% |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segmentation | Application, ownership |
Companies Covered | Concentra, Inc.; Urgent Care MSO, LLC; American Family Care; U.S. HealthWorks Medical Group. |
Application Insights
Based on application, the market is segmented into acute respiratory infection, general symptoms, injuries, joint/soft tissue issues, digestive system issues, skin infections, urinary tract infections, ear infections, sprains, strains and fracture, influenza pneumonia, diseases of the respiratory tract, and others.
Acute respiratory infection dominated the U.S. urgent care market in 2021 and is expected to maintain its dominance over the forecast period. Increasing environmental pollution such as indoor air pollution from burning fuels, air pollution from traffic, tobacco smoke, and industrial sources is anticipated to contribute to the alarming rise in prevalence of respiratory conditions. This segment is also expected to register the fastest growth over the forecast period, followed by urinary tract infections.
Ownership Insights
Based on ownership, the U.S. market has been segmented into hospitals and joint ventures, corporations, physicians, and others. The hospital-owned urgent care and JV segment dominated the market in 2021 and this trend is likely to continue over the course of the forecast period.
The growth of hospital-owned urgent care centers is primarily driven by patient compliance. According to the Urgent Care Association of America, as of 2021, an estimated 16.0% of total urgent care centers were owned by hospitals and about 15.0% were opened in joint ventures with hospitals. The organization also states that UC centers will be beneficial in reducing overcrowding of emergency departments across hospitals, allowing ER doctors to focus on critical cases.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on U.S. Urgent Care Market
5.1. COVID-19 Landscape: U.S. Urgent Care Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global U.S. Urgent Care Market, By Application
8.1. U.S. Urgent Care Market, by Application, 2022-2030
8.1.1. Acute respiratory infection
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. General Symptoms
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Injuries
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Joint/Soft Tissue Issues
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Digestive System Issues
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Skin Infections
8.1.6.1. Market Revenue and Forecast (2017-2030)
8.1.7. Urinary Tract Infections
8.1.7.1. Market Revenue and Forecast (2017-2030)
8.1.8. Ear Infections
8.1.8.1. Market Revenue and Forecast (2017-2030)
8.1.9. Sprains, Strains, and Fracture
8.1.9.1. Market Revenue and Forecast (2017-2030)
8.1.10. Influenza Pneumonia
8.1.10.1. Market Revenue and Forecast (2017-2030)
8.1.11. Disease of Respiratory Tract
8.1.11.1. Market Revenue and Forecast (2017-2030)
8.1.12. Others
8.1.12.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global U.S. Urgent Care Market, By Ownership
9.1. U.S. Urgent Care Market, by Ownership, 2022-2030
9.1.1. Hospital
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Corporation
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Physicians
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global U.S. Urgent Care Market, Regional Estimates and Trend Forecast
10.1. U.S.
10.1.1. Market Revenue and Forecast, by Application (2017-2030)
10.1.2. Market Revenue and Forecast, by Ownership (2017-2030)
Chapter 11. Company Profiles
11.1. Concentra, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Urgent Care MSO, LLC
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. American Family Care
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. The U.S. Health Works Medical Group
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms